Sarah Premji, MD, is a medical oncologist specializing in breast oncology. She serves as Assistant Director of Breast Cancer Research at the Sarah Cannon Research Institute in Nashville, where she oversees breast oncology research operations and provides patient care with SCRI Oncology Partners. Her clinical practice focuses on breast oncology, community-based clinical trials, and precision cancer care. Her research interests include targeted therapies such as antibody-drug conjugates and SERDs, immuno-oncology, and patient-centered outcomes to expand access to innovative treatments. Dr. Premji has been recognized with the ASCO Conquer Cancer Young Investigator Award and holds a leadership role guiding breast oncology research at Sarah Cannon. She earned her medical degree from the Medical College of Georgia, completed internal medicine residency at Baylor College of Medicine, and pursued hematology/oncology fellowship training at Mayo Clinic.
Medical School
2012 – 2016
Residency
2016 – 2019
Fellowship
2022 – 2025